Assignment of patients diagnosed with acute myeloid leukemia (AML) to the 2022 European LeukemiaNet (ELN) favorable genetic risk group has important clinical implications, as allogeneic stem cell transplantation in first complete remission (CR) is not advised due to a relatively good outcome of patients receiving chemotherapy alone and transplant-associated mortality. However, not all favorable genetic risk patients experience long-term relapse-free survival (RFS), making recognition of patients who would most likely be cured of high importance. We analyzed 297 patients aged <60 years with AML classified as 2022 ELN favorable genetic risk who achieved a CR and had RNA sequencing (RNA-seq) and gene mutation data from diagnostic samples available (Alliance trial A152010). To identify prognostically relevant transcripts that can distinguish patients cured from patients susceptible to lower or higher risk of relapse or death, we fit a regularized mixture cure model (MCM) where RNA-seq expression values were our candidate covariates. To validate the identified transcripts, we analyzed 75 patients with AML aged <60 years included in the 2022 ELN favorable genetic risk group who achieved a CR in an independent test set from Gene Expression Omnibus (GSE37642). Our MCM identified 145 transcripts associated with cure or long-term RFS and 149 transcripts associated with latency or shorter-term time to relapse. The area under the curve and C-statistic were, respectively, 0.946 and 0.856 for our training set and 0.877 and 0.857 for our test set. Our results suggest that the favorable risk group includes distinct transcriptionally defined subgroups with different biological properties, which may be useful for refining this genetic risk category.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11551470PMC
http://dx.doi.org/10.1016/j.xinn.2024.100719DOI Listing

Publication Analysis

Top Keywords

2022 european
8
european leukemianet
8
acute myeloid
8
myeloid leukemia
8
favorable genetic
8
genetic risk
8
patients
6
improving risk
4
risk stratification
4
stratification 2022
4

Similar Publications

Fit for purpose testing and independent GMP validation of the monocyte activation test.

Curr Res Toxicol

December 2024

Large Molecule Analytical Development, Janssen Biologics LLC (a Johnson and Johnson Company), 200 Great Valley Parkway, Malvern, PA 19355 USA.

The present study describes the "fit for purpose" testing and the independent product-specific GMP validation of the monocyte activation test (MAT) to detect pyrogenic and pro-inflammatory contaminants, MAT Method A, Quantitative Test (European Pharmacopoeia, Ph. Eur. chapter 2.

View Article and Find Full Text PDF

Protein phosphatase 2A (PP2A) plays a central role in myocardial ischemia-reperfusion (I/R) injury. Several studies showed a detrimental function of PP2A by using either overexpression models of the catalytic subunit (PP2Ac) or exogenous inhibitors of PP2Ac. However, all of these approaches underestimate the contribution of regulatory B subunits in modulating the PP2A holoenzyme.

View Article and Find Full Text PDF

MycoNews 2023: Editorial, news, reports, awards, personalia, and book news.

IMA Fungus

February 2024

Trait Diversity and Function, Royal Botanic Gardens, Kew, Surrey TW9 3DS UK.

This fifth annual edition of starts with an editorial on the critical importance of International Mycological Congresses (IMCs) to the health of mycology. Items on Counting down to IMC12, the State of the World's Plants and Fungi 2023, and progress towards Improving nomenclatural stability in medically important fungi follow. Reports are provided of several mycological meetings in 2023: the Asian Mycological Congress, XIX Congress of European Mycologists, a meeting of European Mycological Groups and Societies, the XI Latin American Mycological Congress, Westerdijk Spring Symposium on Fungal Evolution, the Brazilian Society of Mycology, the Annual Meeting of the Mycological Society of China, and the Fifth Iranian Mycological Congress.

View Article and Find Full Text PDF

Synchrotron X-ray micro-computed tomography enhances our knowledge of the skull anatomy of a Late Triassic ecteniniid cynodont with hypercanines.

Anat Rec (Hoboken)

January 2025

Instituto de Plasmas e Fusão Nuclear & Centro de Recursos Naturais e Ambiente (CERENA), Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.

Hypercanines, or hypertrophied canines, are observed in a wide range of both extinct and extant synapsids. In non-mammaliaform cynodonts, the Permo-Triassic forerunners of mammals, long canines are not uncommon, appearing in several unrelated taxa within the clade. Among them is Trucidocynodon riograndensis, a carnivorous ecteniniid cynodont from the Late Triassic of Brazil, which exhibits a specialized dentition, including spear-shaped incisors, very long and narrow canines, and sectorial postcanines with distally oriented cusps, all of which have finely serrated margins.

View Article and Find Full Text PDF

Balloon atrioseptostomy for transposition of the great arteries in Europe: characteristics and outcomes.

Rev Esp Cardiol (Engl Ed)

January 2025

Pediatric Cardiology Department, M3C National reference center, Hospital Necker- Enfants Malades, Assistance Publique-Hôpitaux de Paris, University Paris Cité, Paris, France.

Introduction And Objectives: Balloon atrial septostomy (BAS) improves oxygenation in neonates with transposition of the great arteries (TGA) and restrictive foramen ovale. Currently, there is a global shortage of dedicated BAS catheters, while new unmarked catheters have recently become available at some European centers. This study aimed to characterize BAS outcomes using the currently available BAS catheters in Europe.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!